Health Economics and Outcome Research by WorkSure #healthcareindustry

WorkSure® offers comprehensive HEOR services, delivering critical insights that shape health policy and support clients in demonstrating the value of their products from development to market access.

Demo Video: https://youtu.be/pzCdXdPgL7k

Read More at: https://www.worksure.org/pages/health-economics-outcomes-research/

#healthcare #pharmaceuticals #medicalresearch #drugdevelopment #durgresearch

Facilitation of Medical Research and Communication

WorkSure® FMRC service helps healthcare organizations strategically plan and enhance communication of medical information, supporting research unit establishment and fostering collaboration among KOLs and stakeholders on new drugs, devices, and diseases.

Video Link: https://youtu.be/Tb-BD5fAmWY

Read more at: https://www.worksure.org/pages/facilitation-medical-research-communication/

#fmrc #medicalresearch #medicalcommuncation #medicalinformation #medicalfacilitation #worksure

Kol Management by WorkSure

WorkSure® KOL Management services facilitate strategic partnerships with key opinion leaders, driving forward cutting-edge research and scientific progress.

Check our vide at: https://youtu.be/5oTDes9-r7A

Read more at https://www.worksure.org/pages/kol-management/

#kolmanagement #kolbiotechnology #kolpharmaceuticals #keyopinionleaders, #kollifesciences

Nivolumab Combination Therapy Improves Overall Survival in Patients with Advanced ESCC

 

Japan: A recent study (Doki et al., 2022) published in the New England Journal of Medicine revealed that treatment with nivolumab plus chemotherapy or nivolumab plus ipilimumab results in significantly longer overall survival than chemotherapy alone for patients with previously untreated advanced esophageal squamous cell carcinoma (ESCC).

The researchers conducted a phase 3 trial involving 970 patients with previously untreated, unresectable advanced, recurring, or metastatic ESCC, randomized to receive either nivolumab plus chemotherapy (321 patients), nivolumab plus the monoclonal antibody ipilimumab (325 patients), or chemotherapy alone (324 patients).

Read more at https://lnkd.in/dmjibxkC

About our services: http://www.worksure.org

#patientengagement #patientexperience #clinicaltrials #clinicaldevelopment #clinicalstudies #clinicaldevelopment

WorkSure MedPharma Knowledge Partner & Clinical Research Organization

WorkSure work as MedPharma Knowledge & Tech Partner with the aim to uplift & upgrade scientific perception of healthcare industries. Our Medical Affairs services promote ethical medico marketing practices that paves way for a strong market grip  & regulatory compliance.

We are here with the product & service portfolio that enables Pharma, Med-Device, Biotech, Hospitals, healthcare societies & other related healthcare organization to strengthen medical knowledge, improve medico marketing / medical research efforts and overall organizational image.

Clinical Education - Developing the Educational Strategies and Leadership Skills

Clinical Education is an integral part of health care profession. It involves educational activities/training that help increase the knowledge base and skills of healthcare professionals (physician, pharmacists or nurses) so they could provide efficient and effective services to patients, the public or the profession.

This program helps healthcare professionals to develop their expertise in analyzing practice trends and designing and delivering clinical education. Unprecedented changes as a result of emerging technologies, new approaches to care and shifting demographics faced by the healthcare sector. To overcome these changes there is need for highly proficient clinical educators who can identify learning needs and can develop educational strategies to address requirements within a wide array of clinical practice contexts. Healthcare professionals should have the business perspective and interpersonal skills to successfully lead teams and guide change.

The clinical education programs offered by WorkSure® are specially designed to advance patient care by sharing knowledge among the clinical, paramedical, scientific, marketing and sales personnel. We offer customized educational programs through web-based learning tools and live events designed for physicians, medical laboratory scientists, pharmacists, nurses, transfusion specialists, transplant coordinators and post-graduate students in healthcare. We not only support in developing & delivering in house training modules, but also various online platforms, medical video, animation or multimedia program. Every program reinforces our brand with the most professional production values.

Each program that we develop consists following in built values:

• Provides key stake holders with analysis of educational landscape and optimum educational pathways.
• Develops objective, agenda and strategies for courses and programs.
• Responds to educational needs and develops targeted educational plans.
• Delivers modules within clinical educational service including live programs for clinicians.
• Measures effectiveness of educational programs and reports on the evaluation of each course.
• Acts as a clinical resource within the organization and external stakeholders to provide input and feedback regarding educational pathway planning.

We also provide support in the following areas:

• Reviewing existing research evidence and provides expert opinion to determine effective application in a practice environment.
• Identify possible research opportunities within clinical education to enhance program development and optimize company profile against competitor organizations.
• Conceptualize, design & execute Medical/Paramedic/Nursing Board activities contributing to positive outcomes for clients, care providers, and the health care organization.
• Provides evidence and research based product and therapy application information to support marketing operational and tactile activities in the region.

We identify possible research opportunities within Clinical Education to enhance program development and optimize company profile against competitor organizations. We are dedicated to clinical education services to facilitate continuing education for the professional development of healthcare providers to ensure quality healthcare and patient safety.

CLINICAL EDUCATION PROGRAMS OFFERED BY WORKSURE^® MEDPHARMA CONSULTANCY INCLUDE:

Continued Medical Education Program for HCPs & Patients

We at WorkSure^® help both the healthcare professionals as well as patients. We design and implement continued educational programmes for healthcare and mass education programmes for patients so as to provide healthcare professionals/patient/public with accurate, balanced medical information in an ethical manner for self empowerment.

Role of continued medical education in medical research and healthcare is utmost important as it bridges the gap between academic research and clinical practice. It provides healthcare practitioners (HCPs) with well-balanced, real-world information that is disease-oriented and aligned to patient needs and global healthcare trends.

Medical training to the medical, research, sales & marketing team

WorkSure^® supports in maximizing the marketing management and medical expertise throughout the organization with training programs for the healthcare, pharmaceutical, biotechnology, and medical device industries.

An effective marketing approach involves in-depth investigation of the patients’ needs, identifying latent needs and offering new health services that patients have not explicitly requested.

Sci-Précis: A leap into future of product surveys

What is it?     

WorkSure team of doctors and IT professionals have developed an application, named Sci-Précis, to produce the real time insights for the pharmaceutical drugs or medical devices. This app will have many features such as tracing of product (drug/medical device) feedback, conducting market research, obtaining scientific view points on drugs/devices, measuring KOL perception and data analytics. Sci-précis will obtain access to valuable data (including collaboration with third parties, academics, providers and payers) and then unique granular insights will be developed after merging advanced analytics with visualization and creative technologies. It will shift the strategy base from share of voice to share of insights.

Why this is important?

Pharmaceutical launch is the most critical period of the product cycle as in 85% of cases the product trajectory is set in first 6 months.  Traditionally, inflexible commercial model and limited real-time insights made the dynamic monitoring of pharmaceutical companies performance impossible. With continuous growth in competition, many well planned products’ launch requires swift changes. Today challenges are different. Even product marketing have become more complex and requires more diverse and dynamic process such as granular, real-time insights and rapid reaction. Companies require a fine grain monitoring of local deviations and detailed understanding of local adoption pattern. The wealth of data available from social media platforms, clinical databases, online claims resources, etc., have enhanced the ability of an industry to smartly respond to market complexity and enable the implementation of leading strategies from other industries. In this era, basis of competition have shifted from share of voice towards share of insights.

What do I need to know?

Sci-précis will obtain access to valuable data (epidemiology, product efficiencies and pitfalls, other strategies) and then unique granular insights will be developed after merging advanced analytics with visualization and creative technologies. A real-time experience tracking method has been long sought by many companies to capture products performance immediately, reduce the loss and minimize bias. We believe a product perception in real time can gain insights that can be quickly interpreted. In the fast-changing environment this will be highly beneficial approach during product launches and marketing campaigns. Without the ability of rapid responses with impactful actions, even good insights make the launches and marketing more ineffective and expensive. Sci-précis will flag any potential plan deviations and give the chance to quickly launch corrective course actions. Companies that are able to convert real time insights into rapid corrective actions are able to prioritise the risk and reduce the response time. Furthermore,  a cross-functional design making process is created which is so efficient and effective that is enables rapid commercial tactics adjustment in response to distribution hurdles, customer’s reactions and competitor’s actions.

What could a Pharmaceutical/Medical device/ Biotechnology/Nutraceutical Industry take way from this?

There are 3 main areas in which by using the wealth of data an industry could accelerate their launch marketing and marketing strategy using Sci-précis:

• At patient, prescriber and locality level launch or marketing plans can be individualised by developing differentiated granular customer insights
• The insight monitoring rhythm will be adjusted in such as way that if any deviation is flagged, the corrective actions can be employed at the right time
• This app will also store the full growth footprint and life cycle of key assets to build a more capable and sustainable launch or marketing strategy model.